Cargando…

Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control

Hypertension (HTN) is an important factor in progressive loss of renal function. The kidney can be both a contributor to and a target of HTN. The functional integrity of the kidney is vital for the maintenance of cardiovascular homeostasis. Chronic activation of the renin system causes HTN and, ulti...

Descripción completa

Detalles Bibliográficos
Autor principal:	Rashid, Haroon-Ur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172064/ https://www.ncbi.nlm.nih.gov/pubmed/21949629 http://dx.doi.org/10.2147/IBPC.S12407

Ejemplares similares

Role of aliskiren in blood pressure control and renoprotection
por: Trimarchi, Hernán
Publicado: (2011)

Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
por: Sureshkumar, Kalathil K
Publicado: (2008)

Long-term effects of aliskiren on blood pressure and the renin-angiotensin-aldosterone system in hypertensive hemodialysis patients
por: Morishita, Yoshiyuki, et al.
Publicado: (2012)

Direct Renin Inhibition: Focus on Aliskiren
por: Pool, James L.
Publicado: (2007)

Renin Inhibition with Aliskiren: A Decade of Clinical Experience
por: Pantzaris, Nikolaos-Dimitrios, et al.
Publicado: (2017)

Aliskiren: An orally active renin inhibitor
por: Wal, Pranay, et al.
Publicado: (2011)

Aliskiren suppresses the renin–angiotensin–aldosterone system and reduces blood pressure and albuminuria in elderly chronic kidney disease patients with hypertension
por: Morishita, Yoshiyuki, et al.
Publicado: (2012)

Central integration and neural control of blood pressure during the cold pressor test: a comparison between hydrochlorothiazide and aliskiren
por: Jarvis, Sara S, et al.
Publicado: (2015)

Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect
por: Panahpour, Hamdollah, et al.
Publicado: (2019)

Direct Renin Inhibitor: Aliskiren in Chronic Kidney Disease
por: Morishita, Yoshiyuki, et al.
Publicado: (2012)

Feasibility of fluorescence energy transfer system for imaging the renoprotective effects of aliskiren in diabetic mice
por: Kidokoro, Kengo, et al.
Publicado: (2016)

The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction
por: Verdecchia, Paolo, et al.
Publicado: (2008)

Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension
por: Andersen, Karl
Publicado: (2009)

Aliskiren in Patients Failing to Achieve Blood Pressure Targets With Angiotensin Converting Enzyme Inhibitors or Angiotensin Receptor Blockers
por: Hawkins, Elizabeth B., et al.
Publicado: (2012)

Effects of Aliskiren on Stroke in Rats Expressing Human Renin and Angiotensinogen Genes
por: Schmerbach, Kristin, et al.
Publicado: (2010)

Effects of aliskiren- and ramipril-based treatment on central aortic blood pressure in elderly with systolic hypertension: a substudy of AGELESS
por: Baschiera, Fabio, et al.
Publicado: (2014)

Olfactory receptor 78 modulates renin but not baseline blood pressure
por: Poll, Brian G., et al.
Publicado: (2021)

β1-Adrenoreceptor Polymorphisms and Blood Pressure: 49S Variant Increases Plasma Renin But Not Blood Pressure in Hypertensive Patients
por: Sandilands, Alastair J, et al.
Publicado: (2019)

Antidepressant-like Effects of Renin Inhibitor Aliskiren in an Inflammatory Mouse Model of Depression
por: Alzarea, Sami I., et al.
Publicado: (2022)

Aliskiren – an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension
por: Allikmets, Kristina
Publicado: (2007)

JAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulation
por: Satou, Ryousuke, et al.
Publicado: (2012)

Blood pressure‐independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes
por: Cruz‐López, Edwyn O., et al.
Publicado: (2022)

The Paraventricular Nucleus of the Hypothalamus in Control of Blood Pressure and Blood Pressure Variability
por: Savić, Bojana, et al.
Publicado: (2022)

Impact of care management processes and integration of care on blood pressure control in diabetes
por: Wong, Ken, et al.
Publicado: (2013)

The Central Control of the Blood Pressure
por: Werner, G.
Publicado: (1953)

Impact of Self‐Monitoring of Blood Pressure on Processes of Hypertension Care and Long‐Term Blood Pressure Control
por: Bryant, Kelsey B., et al.
Publicado: (2020)

Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory
por: Chamberlain, Alanna M., et al.
Publicado: (2023)

Successful Treatment of Hypertension in Anuric Hemodialysis Patients with a Direct Renin Inhibitor, Aliskiren
por: Maeda, Yoshitaka, et al.
Publicado: (2011)

Aliskiren, Fosinopril, and Their Outcome on Renin-Angiotensin-Aldosterone System (RAAS) in Rats with Thyroid Dysfunction
por: Farhadi, Susan A. S., et al.
Publicado: (2019)

Hypertension: Community Control of High Blood Pressure
por: Beevers, D G
Publicado: (1994)

Blood Pressure Control and Exaggerated Blood Pressure Response in Nigerians with Essential Hypertension
por: Abiodun, Olugbenga O, et al.
Publicado: (2014)

Blood pressure measurement and blood pressure control in Veterans Affairs medical centers
por: Halloran, Meghan O’, et al.
Publicado: (2023)

Blood and Blood-Pressure
Publicado: (1901)

De-stiffening drug therapy and blood pressure control
por: Safar, Michel E
Publicado: (2010)

Reducing the Blood Pressure–Related Burden of Cardiovascular Disease: Impact of Achievable Improvements in Blood Pressure Prevention and Control
por: Hardy, Shakia T., et al.
Publicado: (2015)

Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study
por: Feitosa, Fabiana G. A. M., et al.
Publicado: (2021)

Out-of-office blood pressure: from measurement to control
por: Baguet, Jean-Philippe
Publicado: (2012)

Azilsartan/chlorthalidone combination therapy for blood pressure control
por: Cheng, Judy WM
Publicado: (2013)

Blood pressure control in type 2 diabetic patients
por: Grossman, Alon, et al.
Publicado: (2017)

Clevidipine for Perioperative Blood Pressure Control in Infants and Children
por: Tobias, Joseph D., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m0kft41c9iovlbuhopfettv3se